Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma
Jan H. Beumer(University of Pittsburgh), Christopher J. Bakkenist(UPMC Hillman Cancer Center)
Cited by 15
Related Papers
The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer<i>in vivo</i>
|Oncotarget|2015|240
ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1
|Nature Communications|2017|104
Pharmacologic ATM but not ATR kinase inhibition abrogates p21-dependent G1 arrest and promotes gastrointestinal syndrome after total body irradiation
|Scientific Reports|2017|20
A quasi-quantitative dual multiplexed immunoblot method to simultaneously analyze ATM and H2AX phosphorylation in human peripheral blood mononuclear cells
|Oncoscience|2015|18
Radiation therapy induces the DNA damage response in peripheral blood
|Oncotarget|2013|16